We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+4.46%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$357B
AUM Growth
-$19.9B
Cap. Flow
-$28.7B
Cap. Flow %
-8.05%
Top 10 Hldgs %
41.46%
Holding
5,604
New
343
Increased
2,742
Reduced
1,552
Closed
348

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.41B
2
NVDA icon
NVIDIA
NVDA
+$2.28B
3
MSFT icon
Microsoft
MSFT
+$2.02B
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.83B
5
FLUT icon
Flutter Entertainment
FLUT
+$962M

Sector Composition

Rank Sector Weight
1 Technology 17.87%
2 Consumer Discretionary 7.14%
3 Financials 7.05%
4 Industrials 4.81%
5 Communication Services 4.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LANV.WS
5051
DELISTED
Lanvin Group Holdings Warrants
LANV.WS
$20 ﹤0.01%
500
CBIO
5052
Crescent Biopharma
CBIO
$555M
$19 ﹤0.01%
1
CUTR
5053
DELISTED
Cutera, Inc.
CUTR
$19 ﹤0.01%
53
KNDI
5054
Kandi Technologies Group
KNDI
$65.7M
$17 ﹤0.01%
14
NKLA
5055
DELISTED
Nikola Corporation Common Stock
NKLA
$14 ﹤0.01%
12
-9,463
-100% -$27K
ACET icon
5056
Adicet Bio
ACET
$84.7M
$13 ﹤0.01%
1
-2
-67% -$38
LSTA icon
5057
Lisata Therapeutics
LSTA
$9.38M
$12 ﹤0.01%
4
-3
-43% -$9
NBTX
5058
Nanobiotix
NBTX
$2.04B
$11 ﹤0.01%
4
-106
-96% -$424
SENS icon
5059
Senseonics Holdings Inc
SENS
$265M
$10 ﹤0.01%
1
FIRY
5060
Firy Inc
FIRY
$152M
$10 ﹤0.01%
2
-2,767
-100% -$14.8K
HEPA
5061
DELISTED
Hepion Pharmaceuticals
HEPA
0
BYSI icon
5062
BeyondSpring
BYSI
$46.5M
$7 ﹤0.01%
4
KZR
5063
DELISTED
Kezar Life Sciences
KZR
$7 ﹤0.01%
+1
New +$7
CMAX
5064
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$7 ﹤0.01%
692
-97
-12% -$155
FTCI icon
5065
FTC Solar
FTCI
$42.1M
$6 ﹤0.01%
1
-10
-91% -$46
JWSM.WS
5066
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$6 ﹤0.01%
250
XMAX
5067
XMAX Inc
XMAX
$558M
$5 ﹤0.01%
7
VATE icon
5068
INNOVATE Corp
VATE
$111M
$5 ﹤0.01%
1
GRMLW
5069
Greenland Mines Ltd Warrant
GRMLW
$5 ﹤0.01%
100
MVST icon
5070
Microvast
MVST
$267M
$4 ﹤0.01%
2
-3,250
-100% -$2.41K
VUZI icon
5071
Vuzix
VUZI
$194M
$4 ﹤0.01%
1
MTEM
5072
DELISTED
Molecular Templates, Inc.
MTEM
$4 ﹤0.01%
102
-373
-79% -$216
SWVLW icon
5073
Swvl Holdings Corp Warrant
SWVLW
$155K
$3 ﹤0.01%
238
OGI
5074
Organigram Holdings
OGI
$136M
$2 ﹤0.01%
1
KYNB
5075
Kyntra Bio
KYNB
$27.5M
0

Similar funds

Barclays's Q4 2024 Portfolio in Review

As of Q4 2024, Barclays held 5,604 positions worth $357B, down 5.3% from $377B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Barclays withdrew a net $28.7B in Q4 2024, closing 348 positions and reducing 1,552 holdings. Its most notable exit was Stericycle Inc, an estimated $97.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Barclays opened a new position in iShares Bitcoin Trust worth $131M.

  • Barclays's largest Q4 2024 buy was iShares Bitcoin Trust: 2,473,064 shares worth $131M.
  • Barclays added most to Honeywell in Q4 2024, an estimated $3.92B increase.
  • Barclays's biggest Q4 2024 reduction was Apple, cutting an estimated $4.41B.
  • Barclays fully exited Stericycle Inc in Q4 2024, selling an estimated $97.3M.
  • Barclays's ten largest holdings make up 41% of its $357B portfolio in Q4 2024.
  • Barclays opened 343 new positions and closed 348 in Q4 2024.
  • Barclays's portfolio value fell 5.3% quarter-over-quarter to $357B.

Based on Barclays's 13F filing for Q4 2024, filed 13 Feb 2025.